Supremin 4 mg/5 ml oralna otopina
| Name | Supremin 4 mg/5 ml oralna otopina |
|---|---|
| Marketing Authorisation Number | HR-H-938159238 |
| Active Substance | butamiratcitrat |
| Composition | 5 ml (1 žličica) oralne otopine sadrži 4 mg butamiratcitrata |
| Pharmaceutical Form | oralna otopina |
| Manufacturer | Pliva Hrvatska d.o.o., Zagreb, Hrvatska Teva Operations Poland Sp. z o.o., Krakow, Poljska Balkanpharma Troyan AD, Troyan, Bugarska |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 17.07.2017 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/243 |
| Registration Number | 381-12-01/30-17-09 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | allowed |
| ATC Code | R05DB13 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
